Cargando…

THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET

PURPOSE: Geographic atrophy (GA) is an advanced, vision-threatening form of age-related macular degeneration (AMD) affecting approximately five million individuals worldwide. To date, there are no approved therapeutics for GA treatment; however, several are in clinical trials. This review focuses on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boyer, David S., Schmidt-Erfurth, Ursula, van Lookeren Campagne, Menno, Henry, Erin C., Brittain, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Retina 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424580/ https://www.ncbi.nlm.nih.gov/pubmed/27902638 http://dx.doi.org/10.1097/IAE.0000000000001392

Ejemplares similares

C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration
por: Yednock, Ted, et al.
Publicado: (2022)

A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Halawa, Omar A., et al.
Publicado: (2021)

CLINICOPATHOLOGIC CORRELATION OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
por: Li, Miaoling, et al.
Publicado: (2019)

Plasma biomarkers of the amyloid pathway are associated with geographic atrophy secondary to age-related macular degeneration
por: Lashkari, Kameran, et al.
Publicado: (2020)

Clinical validation for automated geographic atrophy monitoring on OCT under complement inhibitory treatment
por: Mai, Julia, et al.
Publicado: (2023)

Determinants of Quality of Life in Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Künzel, Sandrine H., et al.
Publicado: (2020)

Geographic atrophy: Mechanism of disease, pathophysiology, and role of the complement system
por: Bakri, Sophie J, et al.
Publicado: (2023)

Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration
por: Schütze, Christopher, et al.
Publicado: (2015)

Local Complement Inhibition for Geographic Atrophy in Age-Related Macular Degeneration: Prospects, Challenges, and Unanswered Questions
por: Keenan, Tiarnan D.L.
Publicado: (2021)

HISTOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Multilayer Approach
por: Li, Miaoling, et al.
Publicado: (2018)

Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
por: Khan, Hannah, et al.
Publicado: (2023)

Complement Inhibitors for Advanced Dry Age-Related Macular Degeneration (Geographic Atrophy): Some Light at the End of the Tunnel?
por: Cruz-Pimentel, Miguel, et al.
Publicado: (2023)

Population Pharmacokinetics and Pharmacodynamics of Lampalizumab Administered Intravitreally to Patients With Geographic Atrophy
por: Le, KN, et al.
Publicado: (2015)

Systemic expression of Alu RNA in patients with geographic atrophy secondary to age-related macular degeneration
por: Yoshida, Hiroyuki, et al.
Publicado: (2019)

Healthcare Resource Utilization and Costs in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Kim, Ashley, et al.
Publicado: (2021)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
por: Borchert, Grace A., et al.
Publicado: (2023)

Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules
por: Nebbioso, Marcella, et al.
Publicado: (2019)

Do patients with unilateral macular neovascularization type 3 need AREDS supplements to slow the progression to advanced age-related macular degeneration?
por: Haj Najeeb, Bilal, et al.
Publicado: (2022)

Quantitative assessment of retinal fluid in neovascular age-related macular degeneration under anti-VEGF therapy
por: Reiter, Gregor S., et al.
Publicado: (2022)

Retinal Vessel Density in Age-Related Macular Degeneration Patients with Geographic Atrophy
por: Hong, Suji, et al.
Publicado: (2022)

RANTES (CCL5) in Patients With Geographic Atrophy Age-Related Macular Degeneration
por: Fonteh, Cheryl N., et al.
Publicado: (2023)

Geographic Atrophy in Age-Related Macular Degeneration: A Tale of Two Stages
por: Keenan, Tiarnan D.L.
Publicado: (2023)

Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy
por: Katschke, Kenneth J., et al.
Publicado: (2018)

Understanding Crohn's disease through genetics
por: Murthy, Aditya, et al.
Publicado: (2014)

Chemokine Profile and the Alterations in CCR5-CCL5 Axis in Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Krogh Nielsen, Marie, et al.
Publicado: (2020)

Publisher Correction: Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy
por: Katschke, Kenneth J., et al.
Publicado: (2018)

Choriocapillaris changes in dry age-related macular degeneration and geographic atrophy: a review
por: Arya, Malvika, et al.
Publicado: (2018)

Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression
por: Thiele, Sarah, et al.
Publicado: (2021)

Prevalence of Geographic Atrophy in Advanced Age-Related Macular Degeneration (AMD) in Daily Practice
por: Abdin, Alaa Din, et al.
Publicado: (2023)

Atrophy of the central neuroretina in patients treated for diabetic macular edema
por: Karst, Sonja G., et al.
Publicado: (2019)

The intraocular implant and visual rehabilitation improve the quality of life of elderly patients with geographic atrophy secondary to age-related macular degeneration
por: Nekolova, Jana, et al.
Publicado: (2022)

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
por: Patel, Sunil S., et al.
Publicado: (2023)

Role of Complement in the Onset of Age-Related Macular Degeneration
por: Piri, Niloofar, et al.
Publicado: (2023)

Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration
por: Sakurada, Yoichi, et al.
Publicado: (2016)

Clinical and Genetic Factors Associated with Progression of Geographic Atrophy Lesions in Age-Related Macular Degeneration
por: Grassmann, Felix, et al.
Publicado: (2015)

Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
por: Patel, Sunil S., et al.
Publicado: (2023)

Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy
por: Pfau, Maximilian, et al.
Publicado: (2022)

Segmentation of macular neovascularization and leakage in fluorescein angiography images in neovascular age-related macular degeneration using deep learning
por: Holomcik, David, et al.
Publicado: (2022)

Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy
por: Tom, Irene, et al.
Publicado: (2020)

Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects
por: Danis, Ronald P, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sul2f526lu39oa7tjcjpj83o8t